cns abscess (1)

Upload: mowna-tamayo

Post on 06-Apr-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/3/2019 CNS Abscess (1)

    1/55

    CNS ABSCESSES

    Nov 10, 2003

    Gebre K Tseggay, MD

  • 8/3/2019 CNS Abscess (1)

    2/55

    CNS ABSCESSES Focal pyogenic infections of the central nervous system

    Exert their effects mainly by:

    Direct involvement & destruction of the brain or spinalcord

    Compression of parenchyma

    Elevation of intracranial pressure

    Interfering with blood &/or CSF flow

    Include: Brain abscess, subdural empyema,

    intracranial epidural abscess, spinal epiduralabscess, spinal cord abscess

  • 8/3/2019 CNS Abscess (1)

    3/55

    BRAIN ABSCESS

    Accounts for ~ 1 in 10,000hospital admissions in US(1500-2500 cases/yr)

    Major improvementsrealized in diagnosis &management the lastcentury, & especially overthe past three decades,

    with:

  • 8/3/2019 CNS Abscess (1)

    4/55

    BRAIN ABSCESS

    Was uniformly fatal before the late 1800s

    Mortality down to 30-60% from WWII-1970s Introduction of abx (penicillin, chloramphenicol...)

    newer surgical techniques

    Mortality down to 0-24% over the past threedecades, with:

    Advent of CT scanning (1974), MRI

    Stereotactic brain biopsy/aspiration techniques

    Further improvement in surgery

    Newer abx (e.g. cephalosporins, metronidazole..) Better treatment of predisposing conditions

  • 8/3/2019 CNS Abscess (1)

    5/55

    CHANGES IN EPIDEMIOLOGYOF BRAIN ABSCESS

    (in the last 2-3 decades)

    Marked drop in mortality overall

    Lower incidence of otogenic brain abscesses improved treatment of chronic ear infections

    With increase in No. of immunosuppressedpatients:

    increased incidence of brain abscessseen in thatpopulation(Transplant, AIDS,)

    More incidence of brain abscess caused byopportunistic pathogens (fungi, toxo)

  • 8/3/2019 CNS Abscess (1)

    6/55

    PATHOPHYSIOLOGY

    Begins as localized cerebritis (1-2 wks)

    Evolves into a collection of pus surrounded by awell-vascularized capsule (3-4 wks)

    Lesion evolution (based on experimental animal models):

    Days 1-3: early cerebritis stage

    Days 4-9: late cerebritis stage Days 10-14: early capsule stage

    > day14: late capsule stage

  • 8/3/2019 CNS Abscess (1)

    7/55

    PATHOGENESIS

    Direct spread from contiguous foci (40-50%)

    Hematogenous (25-35%)

    Penetrating trauma/surgery (10%)

    Cryptogenic (15-20%)

  • 8/3/2019 CNS Abscess (1)

    8/55

    DIRECT SPREAD(from contiguous foci)

    Occurs by: Direct extension through infected bone

    Spread through emissary veins, diploic veins, locallymphatics

    The contiguous foci include:

    Otitis media/mastoiditis

    Sinusitis

    Dental infection (

  • 8/3/2019 CNS Abscess (1)

    9/55

    HEMATOGENOUS SPREAD(from remote foci)

    Sources:

    Empyema, lung abscess, bronchiectasis,endocarditis, wound infections, pelvic

    infections, intra-abdominal source, etc

    may be facilitated by cyanotic HD, AVM.

    Results in brain abscess(es) at middle

    cerebral artery distribution Often multiple

  • 8/3/2019 CNS Abscess (1)

    10/55

    PREDISPOSING CONDITION &LOCATION OF BRAIN ABSCESS

    Otitis/mastoiditis Temporal lobe,Cerebellum

    Frontal/ethmoid sinusitis Frontal lobe

    Sphenoidal sinusitis Frontal lobe,

    Sella turcica

    Dental infection Frontal > temporal lobe.

    Remote source Middle cerebral arterydistribution (often multiple)

  • 8/3/2019 CNS Abscess (1)

    11/55

    Microbiology ofBrain Abscess

    Dependent upon: Site of primary infection

    Patients underlying condition

    Geographic location

    Usually streptococci and anaerobes

    Staph aureus, aerobic GNR common after

    trauma or surgery 30-60 % are polymicrobial

  • 8/3/2019 CNS Abscess (1)

    12/55

    Predisposing Conditions & Microbiology of

    Brain Abscess

    Predisposing Condition Usual Microbial Isolates

    Otitis media or mastoiditis Streptococci (anaerobic or aerobic),

    Bacteroides and Prevotella spp.,

    Enterobacteriaceae

    Sinusitis (frontoethmoid or sphenoid) Streptococci,Bacteroides spp.,

    Enterobacteriaceae, Staph. aureus,

    Haemophilus spp.

    Dental sepsis Fusobacterium, Prevotella and

    Bacteroides spp., streptococciPenetrating trauma or postneurosurgical S. aureus, streptococci,

    Enterobacteriaceae, Clostridium spp.

    PPID,2000

  • 8/3/2019 CNS Abscess (1)

    13/55

    PREDISPOSING CONDITION USUAL MICROBIAL ISOLATES

    Lung abscess, empyema, bronchiectasis Fusobacterium, Actinomyces, BacteroidesPrevotellaspp., streptococci,Nocardia

    Bacterial endocarditis S. aureus, streptococci

    Congenital heart disease Streptococci,Haemophilus spp.

    Neutropenia Aerobic gram-negative bacilli,AspergillusMucorales, Candidaspp.

    Transplantation Aspergillus spp., Candida spp., Mucorales,

    Enterobacteriaceae,Nocardia spp.,

    Toxoplasma gondii

    HIV infection Toxoplasma gondii, Nocardia spp.,Mycobacterium spp.,Listeria

    monocytogenes, Cryptococcus neoformans

    PPID, 2000

  • 8/3/2019 CNS Abscess (1)

    14/55

    MICROBIOLOGY OFBRAIN ABSCESS

    AGENT FREQUENCY (%)

    Streptococci (S. intermedius, including S. anginosus) 6070

    Bacteroidesand Prevotellaspp. 2040

    Enterobacteriaceae 2333

    Staphylococcus aureus 1015

    Fungi* 1015

    Streptococcus pneumoniae

  • 8/3/2019 CNS Abscess (1)

    15/55

    CLINICAL MANIFESTATIONS

    Non-specific symptoms

    Mainly due to the presence of a space-occupying lesion

    H/A, N/V, lethargy, focal neuro signs , seizures

    Signs/symptoms influenced by Location

    Size

    Virulence of organism

    Presence of underlying condition

  • 8/3/2019 CNS Abscess (1)

    16/55

    CLINICAL MANIFESTATIONSOF BRAIN ABSCESS

    Headache 70%Fever 50

    Altered mental status 50-60Triad of above three

  • 8/3/2019 CNS Abscess (1)

    17/55

    CLINICAL MANIFESTATIONS

    Headache

    Often dull, poorly localized (hemicranial?), non-specific

    Abrupt, extremely severe H/A: think meningitis, SAH.

    Sudden worsening in H/A w meningismus: think ruptureof brain abscess into ventricle (often fatal)

  • 8/3/2019 CNS Abscess (1)

    18/55

    LOCATION & CLINICAL FEATURES

    FRONTAL LOBE: H/A, drowsiness, inattention,

    hemiparesis, motor speech disorder, AMS

    TEMPORAL LOBE: Ipsilateral H/A, aphasia,visual field defect

    PARIETAL LOBE: H/A, visual field defects,endocrine disturbances

    CEREBELLUM: Nystagmus, ataxia, vomiting,dysmetria

  • 8/3/2019 CNS Abscess (1)

    19/55

    DIFFERENTIAL DIAGNOSIS

    Malignancy Abscess has hypo-dense center, with surrounding smooth, thin-

    walled capsule, & areas of peripheral enhancement.

    Tumor has diffuse enhancement & irregular borders.

    SPECT (PET scan) may differentiate. CRP too?

    CVA

    Hemorrhage

    Aneurysm Subdural empyema/ICEpidural abscess

  • 8/3/2019 CNS Abscess (1)

    20/55

    DIAGNOSIS

    High index of suspicion

    Contrast CT or MRI

    Drainage/biopsy, if ring enhancinglesion(s) are seen

  • 8/3/2019 CNS Abscess (1)

    21/55

    IMAGING STUDIES

    MRI more sensitive for early

    cerebritis, satellite lesions,necrosis, ring, edema,especially posterior fossa &

    brain stem CT scan 99m Tc brain scan

    very sensitive; usefulwhere CT or MRI not

    available Skull x-ray :insensitive,

    if air seen, considerpossibility of brain abscess

  • 8/3/2019 CNS Abscess (1)

    22/55

    LABORATORY TESTSBRAIN ABSCESS

    Aspirate:Gram/AFB/fungal stains & cultures, cytopathology (+/-PCR for TB)

    WBC Normal in 40% ( only moderate leukocytosis in ~ 50%

    & only 10% have WBC >20,000)

    CRP almost invariably elevated

    ESR Usually moderately elevated

    BC Often negative BUT Should still be done

    LP Contraindicatedin patients with known/suspected brainabscessRisk of herniation 15-30%

    If done, may have normal CSF findings, but:

    Usually elevated CSF protein & cell count (lymphs)

    Unremarkable glucose & CSF cultures rarely positive

    TREATMENT

  • 8/3/2019 CNS Abscess (1)

    23/55

    TREATMENT

    Combined medical & surgical

    Aspiration or excision empirical abx

    Empirical antibiotics are selected based on:

    Likely pathogen (consider primary source, underlying

    condition, & geography) Antibiotic characteristics: usual MICs, CNS

    penetration, activity in abscess cavity

    Modify abx based on stains

    Duration: usually 6-8 wks after surgical excision, a shorter course may suffice

  • 8/3/2019 CNS Abscess (1)

    24/55

    Armstrong ID, Mosby inc 1999

  • 8/3/2019 CNS Abscess (1)

    25/55

    MEDICAL TREATMENTONLY

    Only in pts with prohibitive surgical risk: poor surgical candidate, multiple abscesses, in a dominant location, Abscess size

  • 8/3/2019 CNS Abscess (1)

    26/55

    CTID,2001

  • 8/3/2019 CNS Abscess (1)

    27/55

    SERIAL IMAGING IMPORTANT TO

    MONITOR RESPONSE

  • 8/3/2019 CNS Abscess (1)

    28/55

    Before Rx

    After completion of Rx

    Armstrong ID,Mosby inc 1999

    POOR PROGNOSTIC MARKERS

  • 8/3/2019 CNS Abscess (1)

    29/55

    POOR PROGNOSTIC MARKERSDelayed or missed diagnosis

    Inappropriate antibiotics.Multiple, deep, or multi-loculated abscesses

    Ventricular rupture (80%100% mortality)

    Fungal , resistant pathogens.

    Neurological compromise at presentation

    Short duration w severe AMS,

    Rapidly progressive neuro. Impairment

    Immunosuppressed host

    Poor localization, especially in the posterior fossa (before CT)

    Modified from CTID,2001

  • 8/3/2019 CNS Abscess (1)

    30/55

  • 8/3/2019 CNS Abscess (1)

    31/55

    EPIDURAL ABSCESSES

    Spinal > intracranial (9:1)

    Intracranially, the dura isadherent to bone

    True spinal epiduralspace is presentposteriorly throughoutthe spine, thus posteriorlongitudinal spread of

    infection is common. Anterior spinal epidural

    very rare (usually belowL1 & cervical)

    http://home.mdconsult.com/das/book/body/0/1005/I316.fig
  • 8/3/2019 CNS Abscess (1)

    32/55

    American Family Physician April 1, 2002

    SPINAL EPIDURAL ABSCESS

  • 8/3/2019 CNS Abscess (1)

    33/55

    SPINAL EPIDURAL ABSCESS

    INTRODUCTION

    Rare, 0.2-1.2 per 10,000 hospitaladmissions

    Median age 50 yrs (35 yrs in IVDU)

    Thoracic>lumbar>cervical

    Majority are acquired hematogenously

  • 8/3/2019 CNS Abscess (1)

    34/55

    COMMON PREDISPOSINGCONDITIONS

    HEMATOGENOUS SPREAD: from remoteinfections & w IVDU

    DIRECT SPREAD: Vertebralosteomyelitis, diskitis, decubitus ulcers,penetrating trauma, surgery, epiduralcatheters

    Via paravertebral venous plexus: fromabdominal/pelvic infections

    PATHOGENESIS

  • 8/3/2019 CNS Abscess (1)

    35/55

    PATHOGENESISSPINAL EPIDURAL ABSCESS

    Often begins as a focal disc or disc-vertebraljunction infection

    Damage of spinal cord can be caused by:

    Direct compression Thrombosis, thrombophlebitis

    Interruption of arterial blood supply

    Focal vasculitis

    Bacterial toxins/mediators of inflammation

    Even a small SEA may cause serious sequelae

  • 8/3/2019 CNS Abscess (1)

    36/55

    MICROBIOLOGYSPINAL EPIDURAL ABSCESS

    The most common pathogens are:

    Staph aureus >60%

    Streptococci 18% Aerobic GNR 13%

    Polymicrobial 10%

    (Note: TB may cause up to 25% in some areas)

  • 8/3/2019 CNS Abscess (1)

    37/55

    CLINICAL MANIFESTATIONSSPINAL EPIDURAL ABSCESS

    Four clinical stages have been described:1. Fever and focal back pain;2. Nerve root compression with nerve root

    pain; shooting pain3. Spinal cord compression withaccompanying deficits in motor/sensorynerves, bowel/bladder sphincter function;

    4. Paralysis (respiratory compromise may alsobe present if the cervical cord is involved).

    Armstrong, ID, Mosby inc,2000

    DIAGNOSIS

  • 8/3/2019 CNS Abscess (1)

    38/55

    DIAGNOSISSPINAL EPIDURAL ABSCESS

    (Thinking of it is key, in a pt with fever, severe, focal back pain)

    MRI, CT

    Abscess drainage

    Blood cultures

    Routine Labs rarely helpful ESR,CRP usually elevated, BUT non-specific

    WBC may or may not be elevated

    LP contraindicated

  • 8/3/2019 CNS Abscess (1)

    39/55

    D/DXSPINAL EPIDURAL ABSCESS

    Metastases

    Vertebral diskitis and osteomyelitis

    Meningitis Herpes Zoster infection

    Other disc/bone disease

  • 8/3/2019 CNS Abscess (1)

    40/55

    TREATMENTSPINAL EPIDURAL ABSCESS

    Early surgical decompression/drainage(preferably within first 24h)

    Antibiotics

    Empiric abx should cover Staph, strep, &GNR

    Duration of Rx : 4-6 weeks

  • 8/3/2019 CNS Abscess (1)

    41/55

    (SEA/SDE)

    90% epidural abscesses are spinal

    Most SEA occur in thoracic (the longest)

    Majority of SEA (>70%) are posterior to the cord

    Most SEA caused hematogenous spread &Staph aureus is the leading cause.

    95% SDE are in intracranial

    Majority of SDE pts have associated sinusitis

  • 8/3/2019 CNS Abscess (1)

    42/55

  • 8/3/2019 CNS Abscess (1)

    43/55

    INTRACRANIAL EPIDURALABSCESS

    Less common & less acute than SEA

    Rounded, well-localized (because dura isfirmly adherent to bone)

    Pathogenesis:

    Direct ext. from contiguous foci (sinusitis,otitis/mastoiditis)

    trauma,or surgery

    INTRACRANIAL EPIDURAL ABSCESS

  • 8/3/2019 CNS Abscess (1)

    44/55

    INTRACRANIAL EPIDURAL ABSCESS

    MICROBIOLOGY: Micraerophillic Strep,

    Propioni, Peptostrept, few aerobic gNR,fungi. Postop: Staph, GNR.

    CLINICAL MANIFESTATION: from SOL/ systmicigns of infection

    Fever, HA, N/V, lethargy

    DX:- Think of it, imaging, drainage

    D/Dx: Tumor, other ICAbscesses

    Rx: Surgery + abx

    Mortality w appropriate Rx < 10%

  • 8/3/2019 CNS Abscess (1)

    45/55

    SUBDURAL EMPYEMA

    15-20 % of all focal intracranial infections Motly a complication of sinusitis, otitis

    media, mastoiditis.

    Most common complication of sinusitis(60% of such cases), mostly fromfrontal/ethmoid sinusitis.

    Trauma/post-op & rarely hematogenous M>F

    SUBDURAL EMPYEMA

  • 8/3/2019 CNS Abscess (1)

    46/55

    SUBDURAL EMPYEMAClinical Manifestations

    Fever

    Headache

    Focal Neuro defects

    Vomiting Mental status changes

    Seizures

    Mass effect more common w SDE than w ICEA

    DX: CT, MRI (LP contraindicated)

    Rx: Surgery . Abx (3-6 wks)

  • 8/3/2019 CNS Abscess (1)

    47/55

    (Armstrong, ID,1999, Mosby Inc)

  • 8/3/2019 CNS Abscess (1)

    48/55

    PARASITIC

  • 8/3/2019 CNS Abscess (1)

    49/55

    PARASITICBRAIN ABSCESS

    Toxoplasmosis

    Neurocysticercosis

    Amebic

    Echinococcal

  • 8/3/2019 CNS Abscess (1)

    50/55

    NOCARDIA BRAIN ABSCESS

    Usually in immunosuppresed (CMI)

    >50% no known predisposing factor

    All pts w pulmonary nocardiosis should undergo

    brain imaging to r/o subclinical CNS nocardiosis Rx: Sulfa (T/S invitro synergy), imipenem,

    ceftriaxone, amikacin, minocin Duration of abx

  • 8/3/2019 CNS Abscess (1)

    51/55

    BRAIN ABSCESS IN AIDS

    Toxoplasmosis is the most common Seropositive

    d/dx lymphoma

    Often empiric Rx given & biopsy only non-responders

    Listeria, Nocardia, tb, fungi

  • 8/3/2019 CNS Abscess (1)

    52/55

    BRAIN TB

    Rare cause of brain abscess

    Usually in immunocompromised

    Tuberculoma is a granuloma (not a trueabscess )

    Biopsy/drainage (send for PCR too )

    FUNGAL BRAIN ABSCESS

  • 8/3/2019 CNS Abscess (1)

    53/55

    FUNGAL BRAIN ABSCESS(Aspergillus, Mucor ...)

    IMMUNOCOMPROMISED

    Poor inflammatory response, lessenhancement on CT.

    May present w much more advanceddisease (seizure, stroke more common)

    High mortality

    Rx: aggressive surgery + antifungal

  • 8/3/2019 CNS Abscess (1)

    54/55

    BRAIN ABSCESS SEQUELAE

    Seizure in 30-60%

    Neuro deficits 30-50%

    Mortality 4-20%

    YIELD OF CULTURES

  • 8/3/2019 CNS Abscess (1)

    55/55

    YIELD OF CULTURESSPINAL EPIDURAL ABSCESS

    SOURCE YIELD

    Abscess fluid aspirate 90%

    Blood culture 62%

    CSF* 19%

    *LP often contraindicated